Skip to main content
Erschienen in: Current Atherosclerosis Reports 8/2014

01.08.2014 | Cardiovascular Disease and Stroke (P Perrone-Filardi and S. Agewall, Section Editors)

Thrombus Aspiration in Primary Angioplasty for ST-segment Elevation Myocardial Infarction

verfasst von: Roberta Serdoz, Michele Pighi, Nikolaos V. Konstantinidis, Ismail Dogu Kilic, Sara Abou-Sherif, Carlo Di Mario

Erschienen in: Current Atherosclerosis Reports | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Mechanical reperfusion with primary percutaneous coronary intervention in acute ST-segment-elevation myocardial infarction is superior to fibrinolysis in terms of short-term and long-term outcome, provided that it can be delivered on time and by an experienced team. Balloon angioplasty and stent implantation of an occluded epicardial vessel during ST-segment-elevation myocardial infarction can cause disruption of the frail thrombus containing lesions associated with suboptimal myocardial reperfusion and microcirculatory obstruction. Distal embolization of atherothrombotic material can be prevented by thrombus aspiration during primary angioplasty. Mechanical aspiration via end-hole large-lumen thrombectomy catheters has been shown to improve Thrombolysis in Myocardial Infarction (TIMI) flow and result in a more consistent early resolution of ST-segment elevation in multiple registries. More recently, a more sophisticated quantification of the myocardial damage has been applied using myocardial scintigraphy and magnetic resonance, with no difference between patients treated with thrombectomy and patients treated with conventional therapy. The expectations in terms of lasting mortality benefit raised by the first Dutch single-center randomized trial of thrombectomy versus predilation with plain old balloon angioplasty (Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Myocardial Infarction, TAPAS) were not confirmed by a much larger Swedish trial (Thrombus Aspiration ST-Segment Elevation Myocardial Infarction, TASTE) showing no outcome changes. Although we are waiting for new trials to clarify these controversial results, thrombectomy is still used in selected patients with high thrombus load or with persistent occlusion of the infarct-related artery after wire passage. Here we review the various systems available and discuss their relative merits and the reported results.
Literatur
1.
Zurück zum Zitat Fuster V, Badimon L, Cohen M, et al. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213–20.CrossRefPubMed Fuster V, Badimon L, Cohen M, et al. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213–20.CrossRefPubMed
2.
Zurück zum Zitat De Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation. 1995;92:1408–13.CrossRefPubMed De Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation. 1995;92:1408–13.CrossRefPubMed
3.
Zurück zum Zitat Hussain KM, Gould L, Bharathan T, et al. Arteriographic morphology and intracoronary thrombus in patients with unstable angina, non-Q wave myocardial infarction and stable angina pectoris. Angiology. 1995;46:181–9.CrossRefPubMed Hussain KM, Gould L, Bharathan T, et al. Arteriographic morphology and intracoronary thrombus in patients with unstable angina, non-Q wave myocardial infarction and stable angina pectoris. Angiology. 1995;46:181–9.CrossRefPubMed
4.
Zurück zum Zitat White CJ, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation. 1996;93:253–8.CrossRefPubMed White CJ, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation. 1996;93:253–8.CrossRefPubMed
5.
Zurück zum Zitat Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macro morphology in patients with acute coronary disorders. Lancet. 1991;337:809–12.CrossRefPubMed Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macro morphology in patients with acute coronary disorders. Lancet. 1991;337:809–12.CrossRefPubMed
6.
Zurück zum Zitat Tabata H, Mizuno K, Arakawa K, et al. Angioscopic identification of coronary thrombus in patients with postinfarction angina. J Am Coll Cardiol. 1995;25:1282–5.CrossRefPubMed Tabata H, Mizuno K, Arakawa K, et al. Angioscopic identification of coronary thrombus in patients with postinfarction angina. J Am Coll Cardiol. 1995;25:1282–5.CrossRefPubMed
7.
Zurück zum Zitat Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103:2550–4.CrossRefPubMed Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103:2550–4.CrossRefPubMed
8.
Zurück zum Zitat Freeman MR, Williams AE, Chisholm RJ, et al. Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. Circulation. 1989;80:17–23.CrossRefPubMed Freeman MR, Williams AE, Chisholm RJ, et al. Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. Circulation. 1989;80:17–23.CrossRefPubMed
9.
Zurück zum Zitat Taeymans Y, Theroux P, Lesperance J, et al. Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusion. Circulation. 1992;85:78–85.CrossRefPubMed Taeymans Y, Theroux P, Lesperance J, et al. Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusion. Circulation. 1992;85:78–85.CrossRefPubMed
10.
Zurück zum Zitat Siqueira DA, Abizaid AA, de Ribamar CJ, et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes. Eur Heart J. 2007;28:1304–9.CrossRefPubMed Siqueira DA, Abizaid AA, de Ribamar CJ, et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes. Eur Heart J. 2007;28:1304–9.CrossRefPubMed
11.
Zurück zum Zitat Cook, Cook S, Eshtehardi P, et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J. 2012;33:1334–43.CrossRefPubMed Cook, Cook S, Eshtehardi P, et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J. 2012;33:1334–43.CrossRefPubMed
12.
Zurück zum Zitat Hong MK, Mintz GS, Lee CW, et al. Impact of late drug-eluting stent malapposition on 3-year clinical events. J Am Coll Cardiol. 2007;50:1515–56.CrossRefPubMed Hong MK, Mintz GS, Lee CW, et al. Impact of late drug-eluting stent malapposition on 3-year clinical events. J Am Coll Cardiol. 2007;50:1515–56.CrossRefPubMed
13.
Zurück zum Zitat Guagliumi G, Sirbu V, Musumeci G, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv. 2012;5:12–20.CrossRefPubMed Guagliumi G, Sirbu V, Musumeci G, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv. 2012;5:12–20.CrossRefPubMed
14.
Zurück zum Zitat Mizuno K, Satomura K, Miyamoto A, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287–91.CrossRefPubMed Mizuno K, Satomura K, Miyamoto A, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287–91.CrossRefPubMed
15.
Zurück zum Zitat Zhao XQ, Theroux P, Snapinn SM, et al. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms). Circulation. 1999;100:1609–15.CrossRefPubMed Zhao XQ, Theroux P, Snapinn SM, et al. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms). Circulation. 1999;100:1609–15.CrossRefPubMed
16.
Zurück zum Zitat Di Mario C, Gorge G, Peters R, et al. Clinical application and image interpretation in intracoronary ultrasound. Eur Heart J. 1998;19:207–29.CrossRefPubMed Di Mario C, Gorge G, Peters R, et al. Clinical application and image interpretation in intracoronary ultrasound. Eur Heart J. 1998;19:207–29.CrossRefPubMed
17.
Zurück zum Zitat Siegel RJ, Ariani M, Fishbein MC, et al. Histopathologic validation of angioscopy and intravascular ultrasound. Circulation. 1991;84:109–17.CrossRefPubMed Siegel RJ, Ariani M, Fishbein MC, et al. Histopathologic validation of angioscopy and intravascular ultrasound. Circulation. 1991;84:109–17.CrossRefPubMed
18.
Zurück zum Zitat Milosz J, Klingenberg R, Landmesser U. Intracoronary near-infrared spectroscopy (NIRS) imaging for detection of lipid content of coronary plaques: current experience and future perspectives. Curr Cardiovasc Imaging Rep. 2013;6:426–30.CrossRef Milosz J, Klingenberg R, Landmesser U. Intracoronary near-infrared spectroscopy (NIRS) imaging for detection of lipid content of coronary plaques: current experience and future perspectives. Curr Cardiovasc Imaging Rep. 2013;6:426–30.CrossRef
19.
Zurück zum Zitat Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35.CrossRefPubMed Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35.CrossRefPubMed
20.
Zurück zum Zitat Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, et al. Changes in plaque lipid content after short-term intensive versus standard statin therapy. The YELLOW trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy). J Am Coll Cardiol. 2013;62(1):21–9.CrossRefPubMed Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, et al. Changes in plaque lipid content after short-term intensive versus standard statin therapy. The YELLOW trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy). J Am Coll Cardiol. 2013;62(1):21–9.CrossRefPubMed
21.
Zurück zum Zitat Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol. 2006;97:1713–7.CrossRefPubMed Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol. 2006;97:1713–7.CrossRefPubMed
22.
Zurück zum Zitat Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933–9.CrossRefPubMed Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933–9.CrossRefPubMed
23.
Zurück zum Zitat Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111:1551–5.PubMedCentralCrossRefPubMed Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111:1551–5.PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Imola F, Mallus MT, Ramazzotti V, et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention. 2010;6:575–81.CrossRefPubMed Imola F, Mallus MT, Ramazzotti V, et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention. 2010;6:575–81.CrossRefPubMed
25.
Zurück zum Zitat Gutiérrez-Chico JL, Alegría-Barrero E, Teijeiro-Mestre R, et al. Optical coherence tomography: from research to practice. Eur Heart J Cardiovasc Imaging. 2012;13:370–84.PubMedCentralCrossRefPubMed Gutiérrez-Chico JL, Alegría-Barrero E, Teijeiro-Mestre R, et al. Optical coherence tomography: from research to practice. Eur Heart J Cardiovasc Imaging. 2012;13:370–84.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Hata K, Whittaker P, Kloner RA, et al. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine. Circulation. 1998;97:692–702.CrossRefPubMed Hata K, Whittaker P, Kloner RA, et al. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine. Circulation. 1998;97:692–702.CrossRefPubMed
27.
Zurück zum Zitat Hori M, Inoue M, Kitakaze M, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol. 1986;250:509–18. Hori M, Inoue M, Kitakaze M, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol. 1986;250:509–18.
28.
Zurück zum Zitat Cura FA, Roffi M, Pasca N, et al. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). Am J Cardiol. 2004;94:859–63.CrossRefPubMed Cura FA, Roffi M, Pasca N, et al. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). Am J Cardiol. 2004;94:859–63.CrossRefPubMed
29.
Zurück zum Zitat Shah PK, Cercek B, Lew AS, et al. Angiographic validation of bedside markers of reperfusion. J Am Coll Cardiol. 1993;21:55–61.CrossRefPubMed Shah PK, Cercek B, Lew AS, et al. Angiographic validation of bedside markers of reperfusion. J Am Coll Cardiol. 1993;21:55–61.CrossRefPubMed
30.
Zurück zum Zitat Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99:1945–50.CrossRefPubMed Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99:1945–50.CrossRefPubMed
31.
Zurück zum Zitat Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002;105:1909–13.CrossRefPubMed Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002;105:1909–13.CrossRefPubMed
32.
Zurück zum Zitat Montisci R, Chen L, Ruscazio M, et al. Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction. Heart. 2006;92:1113–8.PubMedCentralCrossRefPubMed Montisci R, Chen L, Ruscazio M, et al. Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction. Heart. 2006;92:1113–8.PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Shah A, Wagner GS, Granger CB, et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol. 2000;35:666–72.CrossRefPubMed Shah A, Wagner GS, Granger CB, et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol. 2000;35:666–72.CrossRefPubMed
34.
Zurück zum Zitat Bodi V, Sanchis J, Lopez-Lereu MP, et al. Evolution of 5 cardiovascular magnetic resonance-derived viability indexes after reperfused myocardial infarction. Am Heart J. 2007;153:649–55.CrossRefPubMed Bodi V, Sanchis J, Lopez-Lereu MP, et al. Evolution of 5 cardiovascular magnetic resonance-derived viability indexes after reperfused myocardial infarction. Am Heart J. 2007;153:649–55.CrossRefPubMed
35.
Zurück zum Zitat Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699–708.CrossRefPubMed Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699–708.CrossRefPubMed
36.
Zurück zum Zitat Galiuto L, Garramone B, Burzotta F, et al. Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA trial. J Am Coll Cardiol. 2006;48:1355–60.CrossRefPubMed Galiuto L, Garramone B, Burzotta F, et al. Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA trial. J Am Coll Cardiol. 2006;48:1355–60.CrossRefPubMed
37.
Zurück zum Zitat Tarantini G, Razzolini R, Cacciavillani L, et al. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol. 2006;98:1033–40.CrossRefPubMed Tarantini G, Razzolini R, Cacciavillani L, et al. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol. 2006;98:1033–40.CrossRefPubMed
38.
Zurück zum Zitat Tan K, Sulke N, Taub N, et al. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25:855–65.CrossRefPubMed Tan K, Sulke N, Taub N, et al. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25:855–65.CrossRefPubMed
39.
Zurück zum Zitat Rittersma SZ, van der Wal AC, Koch KT, et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation. 2005;111:1160–5.CrossRefPubMed Rittersma SZ, van der Wal AC, Koch KT, et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation. 2005;111:1160–5.CrossRefPubMed
40.
Zurück zum Zitat Hara H, Nakamura M, Komatsu H, et al. Comparison of the in vitro performance of 6 and 7 French aspiration catheters. EuroIntervention. 2007;2:487–92.PubMed Hara H, Nakamura M, Komatsu H, et al. Comparison of the in vitro performance of 6 and 7 French aspiration catheters. EuroIntervention. 2007;2:487–92.PubMed
41.
Zurück zum Zitat Rioufol G, Collin B, Vincent-Martin M, et al. Large tube section is the key to successful coronary thrombus aspiration: findings of a standardized bench test. Catheter Cardiovasc Interv. 2006;67:254–7.CrossRefPubMed Rioufol G, Collin B, Vincent-Martin M, et al. Large tube section is the key to successful coronary thrombus aspiration: findings of a standardized bench test. Catheter Cardiovasc Interv. 2006;67:254–7.CrossRefPubMed
42.
Zurück zum Zitat Constantinides S, Lo TS, Been M, et al. Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis. Heart. 2002;87:455–60.PubMedCentralCrossRefPubMed Constantinides S, Lo TS, Been M, et al. Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis. Heart. 2002;87:455–60.PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Young JJ, Cox DA, Stuckey T, et al. Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registry. J Interv Cardiol. 2007;20:44–50.CrossRefPubMed Young JJ, Cox DA, Stuckey T, et al. Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registry. J Interv Cardiol. 2007;20:44–50.CrossRefPubMed
44.
Zurück zum Zitat Lefevre T, Garcia E, Reimers B, et al. X-Sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-Sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J Am Coll Cardiol. 2005;46:246–52.CrossRefPubMed Lefevre T, Garcia E, Reimers B, et al. X-Sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-Sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J Am Coll Cardiol. 2005;46:246–52.CrossRefPubMed
45.
Zurück zum Zitat Stone GW, Cox DA, Babb J, et al. Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. J Am Coll Cardiol. 2003;42:2007–13.CrossRefPubMed Stone GW, Cox DA, Babb J, et al. Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. J Am Coll Cardiol. 2003;42:2007–13.CrossRefPubMed
46.
Zurück zum Zitat De Carlo M, Cortese B, Borelli G, et al. Successful treatment of acute myocardial infarction due to subocclusive thrombosis over a small atherosclerotic plaque with the "Rinspiration" device, a novel thrombectomy catheter. Int J Cardiol. 2007;115:95–6.CrossRefPubMed De Carlo M, Cortese B, Borelli G, et al. Successful treatment of acute myocardial infarction due to subocclusive thrombosis over a small atherosclerotic plaque with the "Rinspiration" device, a novel thrombectomy catheter. Int J Cardiol. 2007;115:95–6.CrossRefPubMed
47.
Zurück zum Zitat Webb J, Chandavimol M, Hamburger JN, et al. Initial experience with a novel coronary rinsing and thrombectomy system: "Rinspiration". J Invasive Cardiol. 2006;18:188–92.PubMed Webb J, Chandavimol M, Hamburger JN, et al. Initial experience with a novel coronary rinsing and thrombectomy system: "Rinspiration". J Invasive Cardiol. 2006;18:188–92.PubMed
48.
Zurück zum Zitat Webb JG, Vaderah S, Hamburger J, et al. Proximal protection during saphenous vein graft angioplasty: the Kerberos embolic protection system. Catheter Cardiovasc Interv. 2005;64:383–6.CrossRefPubMed Webb JG, Vaderah S, Hamburger J, et al. Proximal protection during saphenous vein graft angioplasty: the Kerberos embolic protection system. Catheter Cardiovasc Interv. 2005;64:383–6.CrossRefPubMed
49.
Zurück zum Zitat Antoniucci D, Valenti R, Migliorini A, et al. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2004;93:1033–5.CrossRefPubMed Antoniucci D, Valenti R, Migliorini A, et al. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2004;93:1033–5.CrossRefPubMed
50.
Zurück zum Zitat Ali A, Cox D, Dib N, et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol. 2006;48:244–52.CrossRefPubMed Ali A, Cox D, Dib N, et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol. 2006;48:244–52.CrossRefPubMed
51.
Zurück zum Zitat Migliorini A, Stabile A, Rodriguez AE, et al. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol. 2010;56:1298–306.CrossRefPubMed Migliorini A, Stabile A, Rodriguez AE, et al. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol. 2010;56:1298–306.CrossRefPubMed
52.
Zurück zum Zitat Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). Am J Cardiol. 2004;93:694–701.CrossRefPubMed Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). Am J Cardiol. 2004;93:694–701.CrossRefPubMed
53.
Zurück zum Zitat Dorr M, Vogelgesang D, Hummel A, et al. Excimer laser thrombus elimination for prevention of distal embolization and no-reflow in patients with acute ST elevation myocardial infarction: results from the randomized LaserAMI study. Int J Cardiol. 2007;116:20–6.CrossRefPubMed Dorr M, Vogelgesang D, Hummel A, et al. Excimer laser thrombus elimination for prevention of distal embolization and no-reflow in patients with acute ST elevation myocardial infarction: results from the randomized LaserAMI study. Int J Cardiol. 2007;116:20–6.CrossRefPubMed
54.
Zurück zum Zitat Ambrosini V, Cioppa A, Salemme L, et al. Excimer laser in acute myocardial infarction: single centre experience on 66 patients. Int J Cardiol. 2008;127:98–102.CrossRefPubMed Ambrosini V, Cioppa A, Salemme L, et al. Excimer laser in acute myocardial infarction: single centre experience on 66 patients. Int J Cardiol. 2008;127:98–102.CrossRefPubMed
55.
Zurück zum Zitat Latib A, Takagi K, Chizzola G, Tobis J, Ambrosini V, et al. Excimer laser lesion modification to expand non-dilatable stents: the ELLEMENT registry. Cardiovasc Revasc Med. 2014;15(1):8–12.CrossRefPubMed Latib A, Takagi K, Chizzola G, Tobis J, Ambrosini V, et al. Excimer laser lesion modification to expand non-dilatable stents: the ELLEMENT registry. Cardiovasc Revasc Med. 2014;15(1):8–12.CrossRefPubMed
56.
Zurück zum Zitat Pershad A, Sein V, Laufer N, et al. GuideLiner catheter facilitated PCI – a novel device with multiple applications. J Invasive Cardiol. 2011;23:254–9. Pershad A, Sein V, Laufer N, et al. GuideLiner catheter facilitated PCI – a novel device with multiple applications. J Invasive Cardiol. 2011;23:254–9.
57.
Zurück zum Zitat Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Di Mario C, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial. Circulation. 2003;108(1):37–42.CrossRefPubMed Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Di Mario C, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial. Circulation. 2003;108(1):37–42.CrossRefPubMed
58.
Zurück zum Zitat Tyczynski P, Kukreja N, van Geuns RJ, et al. Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts. EuroIntervention. 2010;6:78–85.CrossRefPubMed Tyczynski P, Kukreja N, van Geuns RJ, et al. Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts. EuroIntervention. 2010;6:78–85.CrossRefPubMed
59.
Zurück zum Zitat Dziewierz A, Dudek D. Advantages of MGuard coronary stent system. Minerva Cardioangiol. 2012;60:33–40.PubMed Dziewierz A, Dudek D. Advantages of MGuard coronary stent system. Minerva Cardioangiol. 2012;60:33–40.PubMed
60.
Zurück zum Zitat Cassese S, Esposito G, Mauro C, et al. MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial Infarction pAtieNts—(GUARDIAN) trial: study design and rationale. Catheter Cardiovasc Interv. 2012;79:1118–26.CrossRefPubMed Cassese S, Esposito G, Mauro C, et al. MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial Infarction pAtieNts—(GUARDIAN) trial: study design and rationale. Catheter Cardiovasc Interv. 2012;79:1118–26.CrossRefPubMed
61.
Zurück zum Zitat Stone GW, Abizaid A, Silber S, Dizon JM, Merkely B, et al. Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: the MASTER trial. J Am Coll Cardiol. 2012;60:1975–84.CrossRef Stone GW, Abizaid A, Silber S, Dizon JM, Merkely B, et al. Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: the MASTER trial. J Am Coll Cardiol. 2012;60:1975–84.CrossRef
62.
Zurück zum Zitat Burzotta F, Trani C, Romagnoli E, et al. Manual thrombus-aspiration improves myocardial reperfusion: the Randomized Evaluation of the Effect of Mechanical Reduction of Distal Embolization by Thrombus-Aspiration in Primary and Rescue Angioplasty (REMEDIA) trial. J Am Coll Cardiol. 2005;46:371–6.CrossRefPubMed Burzotta F, Trani C, Romagnoli E, et al. Manual thrombus-aspiration improves myocardial reperfusion: the Randomized Evaluation of the Effect of Mechanical Reduction of Distal Embolization by Thrombus-Aspiration in Primary and Rescue Angioplasty (REMEDIA) trial. J Am Coll Cardiol. 2005;46:371–6.CrossRefPubMed
63.
Zurück zum Zitat De Luca L, Sardella G, Davidson CJ, et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart. 2006;92:951–7.PubMedCentralCrossRefPubMed De Luca L, Sardella G, Davidson CJ, et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart. 2006;92:951–7.PubMedCentralCrossRefPubMed
64.
Zurück zum Zitat Silva-Orrego P, Colombo P, Bigi R, et al. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J Am Coll Cardiol. 2006;48:1552–9.CrossRefPubMed Silva-Orrego P, Colombo P, Bigi R, et al. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J Am Coll Cardiol. 2006;48:1552–9.CrossRefPubMed
65.
Zurück zum Zitat De Luca G, Suryapranata H, Stone G, et al. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J. 2007;153:343–53.CrossRefPubMed De Luca G, Suryapranata H, Stone G, et al. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J. 2007;153:343–53.CrossRefPubMed
66.
Zurück zum Zitat Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557–67.CrossRefPubMed Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557–67.CrossRefPubMed
67.
Zurück zum Zitat Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008;371:1915–20.CrossRefPubMed Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008;371:1915–20.CrossRefPubMed
68.
Zurück zum Zitat De Luca G, Dudek D, Sardella G, et al. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J. 2008;29:3002–10.CrossRefPubMed De Luca G, Dudek D, Sardella G, et al. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J. 2008;29:3002–10.CrossRefPubMed
69.
Zurück zum Zitat Burzotta F, De Vita M, et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J. 2009;30:2193–203.CrossRefPubMed Burzotta F, De Vita M, et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J. 2009;30:2193–203.CrossRefPubMed
70.
Zurück zum Zitat Frobert O, Lagerqvist B, Gudnason T, et al. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish Angiography and Angioplasty Registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160:1042–8.CrossRefPubMed Frobert O, Lagerqvist B, Gudnason T, et al. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish Angiography and Angioplasty Registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160:1042–8.CrossRefPubMed
71.
Zurück zum Zitat Muller-Hulsbeck S, Grimm J, Leidt J, et al. Comparison of in vitro effectiveness of mechanical thrombectomy devices. J Vasc Interv Radiol. 2001;12:1185–91.CrossRefPubMed Muller-Hulsbeck S, Grimm J, Leidt J, et al. Comparison of in vitro effectiveness of mechanical thrombectomy devices. J Vasc Interv Radiol. 2001;12:1185–91.CrossRefPubMed
72.
Zurück zum Zitat Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, et al. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6(3):283–7.CrossRefPubMed Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, et al. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6(3):283–7.CrossRefPubMed
73.
Zurück zum Zitat Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–619.CrossRefPubMed Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–619.CrossRefPubMed
Metadaten
Titel
Thrombus Aspiration in Primary Angioplasty for ST-segment Elevation Myocardial Infarction
verfasst von
Roberta Serdoz
Michele Pighi
Nikolaos V. Konstantinidis
Ismail Dogu Kilic
Sara Abou-Sherif
Carlo Di Mario
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Current Atherosclerosis Reports / Ausgabe 8/2014
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-014-0431-3

Weitere Artikel der Ausgabe 8/2014

Current Atherosclerosis Reports 8/2014 Zur Ausgabe

Cardiovascular Disease and Stroke (P Perrone-Filardi and S. Agewall, Section Editors)

HDL: To Treat or Not To Treat?

Cardiovascular Disease and Stroke (P Perrone-Filardi and S. Agewall, Section Editors)

New Risk Markers for Cardiovascular Prevention

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.